IRADIMED CORP — Director's Dealing 2022

Oct 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-10-14

Reporting Person: Scharen-Guivel Hilda Frederique (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-14	Restricted Stock Units	$	A	5300	Acquired		Common Stock (5300)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on October 14, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.